Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 142,131 | 251,177 | 284,803 | 848,537 | 336,326 |
| Marketable Securities | 352,517 | 280,739 | 328,359 | N/A | N/A |
| Receivables | 3,691 | 6,500 | 2,435 | 12,090 | 325 |
| TOTAL | $509,539 | $550,652 | $628,298 | $874,713 | $339,544 |
| Non-Current Assets | |||||
| PPE Net | 4,895 | 4,696 | 2,121 | 2,072 | 1,352 |
| Investments And Advances | 160,354 | 100,539 | 118,225 | 0 | 0 |
| Other Non-Current Assets | 12,188 | 11,701 | 6,347 | 7,927 | 3,662 |
| TOTAL | $177,437 | $116,936 | $126,693 | $9,999 | $5,014 |
| Total Assets | $686,976 | $667,588 | $754,991 | $884,712 | $344,558 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,503 | 21,080 | 7,662 | 5,145 | 3,026 |
| Accrued Expenses | 29,124 | 15,620 | 19,727 | 17,157 | 7,486 |
| TOTAL | $40,360 | $40,014 | $42,000 | $304,124 | $14,998 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,397 | 2,063 | 13,775 | 281,052 | 4,486 |
| Other Non-Current Liabilities | 56,322 | 52,346 | 49,659 | 27,768 | 6,363 |
| TOTAL | $56,322 | $52,346 | $49,659 | $27,768 | $6,363 |
| Total Liabilities | $96,682 | $92,360 | $91,659 | $331,892 | $21,361 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,194 | 35,843 | 35,720 | 35,515 | 35,099 |
| Common Shares | 37 | 36 | 36 | 35 | 35 |
| Retained earnings | -9,781 | 124,633 | 237,275 | 140,623 | -73,898 |
| Other shareholders' equity | -15,999 | -13,240 | -9,644 | -1,018 | 617 |
| TOTAL | $590,294 | $575,228 | $663,332 | $552,820 | $323,197 |
| Total Liabilities And Equity | $686,976 | $667,588 | $754,991 | $884,712 | $344,558 |